Adjuvant chemotherapy in older patients with stage III colon cancer: An underused lifesaving treatment

Journal of Clinical Oncology

Volumn 30, Issue 21, 2012, Pages 2576-2578

  Muss, Hyman B ^a   Bynum, Debra L ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; COLON CANCER; DIARRHEA; EDITORIAL; HUMAN; NAUSEA AND VOMITING; NEUROTOXICITY; NEUTROPENIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE;

EID: 84864035563     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.42.3780     Document Type: Editorial

References (22)

1. National Center for Health Statistics: Tables on trends in health and aging: Life expectancy. http://www.cdc.gov/nchs/fastats/lifexpec.htm
2. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62:10-29, 2012
3. Howlader N, Noone AM, Krapcho M, et al: SEER Cancer Statistics Review, 1975-2008. Bethesda, MD, National Cancer Institute, 2011
4. Sanoff HK, Carpenter WR, Stürmer T, et al: Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol 30:2624-2634, 2012
5. Sargent DJ, Goldberg RM, Jacobson SD, et al: A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345:1091-1097, 2001
6. André T, Boni C, Navarro M, et al: Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27:3109, 2009
7. Kuebler JP, Wieand HS, O'Connell MJ, et al: Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: Results from NSABP C-07. J Clin Oncol 25:2198-2204, 2007 (Pubitemid 46954643)
8. Jackson McCleary NA, Meyerhardt J, Green E, et al: Impact of older age on the efficacy of newer adjuvant therapies in > 12,500 patients (pts) with stage II/III colon cancer: Findings from the ACCENT database. J Clin Oncol 27:170s, 2009 (suppl 15; abstr 4010)
9. Mulcahy HE, Patchett SE, Daly L, et al: Prognosis of elderly patients with large bowel cancer. Br J Surg 81:736-738, 1994 (Pubitemid 24192114)
10. Sanoff HK, Carpenter WR, Freburger J, et al: Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: A Population-based analysis. Cancer [epub ahead of print on January 31, 2012]
11. Kahn KL, Adams JL, Weeks JC, et al: Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA 303:1037-1045, 2010
12. André T, Boni C, Mounedji-Boudiaf L, et al: Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343-2351, 2004 (Pubitemid 38702845)
13. Land SR, Kopec JA, Cecchini RS, et al: Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07. J Clin Oncol 25:2205-2211, 2007 (Pubitemid 46954644)
14. Hurria A, Cirrincione CT, Muss HB, et al: Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol 29:1290-1296, 2011
15. Aaldriks AA, Maartense E, le Cessie S, et al: Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Crit Rev Oncol Hematol 79:205-212, 2011
16. Pallis AG, Wedding U, Lacombe D, et al: Questionnaires and instruments for a multidimensional assessment of the older cancer patient: What clinicians need to know? Eur J Cancer 46:1019-1025, 2010
17. Hurria A: Geriatric assessment in oncology practice. J Am Geriatr Soc 57:S246-S249, 2009 (suppl 2)
18. Hurria A, Cirrincione CT, Muss HB, et al: Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol 29:1290-1296, 2011
19. Hutchins LF, Unger JM, Crowley JJ, et al: Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341:2061-2067, 1999 (Pubitemid 30035956)
20. Zulman DM, Sussman JB, Chen X, et al: Examining the evidence: A systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med 26:783-790, 2011
21. Seymour MT, Thompson LC, Wasan HS, et al: Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): An open-label, randomised factorial trial. Lancet 377:1749-1759, 2011
22. Applegate WB, Blass JP, Williams TF: Instruments for the functional assessment of older patients. N Engl J Med 322:1207-1214, 1990 (Pubitemid 20137853)